Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Genesys Capital is a life sciences venture capital firm founded in 2000 and headquartered in Toronto, Canada. The firm has established itself as a key player in the early-stage investment landscape, focusing on life sciences companies that are poised to make significant medical breakthroughs. Over the years, Genesys has raised more than $400 million across five venture funds, which has enabled them to build a diverse portfolio of 44 companies.
With a strong emphasis on collaboration, Genesys Capital partners with scientific founders and entrepreneurs, leveraging a deep scientific network and relationships with leading research institutes and universities. This approach not only enhances their investment strategy but also positions them as a valuable ally for startups in the healthcare sector.
Genesys Capital exclusively invests in early-stage life sciences companies, targeting funding stages from pre-seed to Series A. Their investment strategy is centered around the biotech and healthcare sectors, where they seek to identify and support innovative solutions that can address pressing medical challenges. The firm typically collaborates closely with scientific founders, emphasizing the importance of scientific rigor and entrepreneurial spirit in their investment decisions.
The firm’s check sizes vary depending on the stage of investment, but they are known for their commitment to providing substantial support to their portfolio companies. Genesys Capital's geographic focus is primarily on North America, particularly Canada, where they aim to foster the growth of life sciences innovations.
Genesys Capital has built a notable portfolio of 44 companies, showcasing their commitment to the life sciences sector. Key portfolio companies include:
These companies exemplify Genesys Capital's focus on innovative healthcare solutions and their ability to identify high-potential investments in the life sciences arena.
Jennifer Williams: Partner and Chief Financial Officer, brings extensive experience in finance and investment management.
Damian Lamb: Co-founder and Managing Director, has a strong background in venture capital and life sciences investments.
Lisa Low: Senior Vice President, Finance, specializes in financial strategy and operations within the venture capital space.
Kelly Holman: Co-founder and Managing Director, focuses on identifying and supporting innovative healthcare startups.
Sarah Farr: Principal, involved in sourcing and evaluating investment opportunities in the life sciences sector.
Jamie Stiff: Managing Director, brings expertise in operational support and strategic growth for portfolio companies.
Christine Thoburn: Office Manager, oversees administrative functions and supports the team’s operations.
To pitch to Genesys Capital, founders should use the preferred channel of their website or email. A comprehensive pitch deck is essential, detailing the business model, market opportunity, and team qualifications. Response times can vary, but founders are encouraged to provide a warm introduction if possible.
In recent months, Genesys Capital has continued to strengthen its portfolio with significant investments in early-stage life sciences companies. Notable exits include the acquisition of Fusion Pharmaceuticals Inc. by AstraZeneca for $2.4 billion and Inversago Pharma by Novo Nordisk for $1.1 billion, showcasing the firm's successful investment strategy.
The firm remains active in the venture capital space, focusing on identifying and supporting innovative healthcare solutions that can lead to medical breakthroughs.
What are Genesys Capital's investment criteria?
Genesys Capital invests exclusively in early-stage life sciences companies, focusing on pre-seed to Series A stages. They look for innovative solutions in the biotech and healthcare sectors, emphasizing collaboration with scientific founders.
How can I apply or pitch to Genesys Capital?
Founders can pitch their ideas through the firm’s website at genesyscapital.com or by emailing info@genesyscapital.com. A detailed pitch deck that outlines the business model, market opportunity, and team is recommended.
What makes Genesys Capital different from other venture firms?
Genesys Capital distinguishes itself through its strong emphasis on collaboration with scientific innovators and its deep connections within the life sciences community. This enables them to provide valuable insights and support to their portfolio companies.
What is the geographic scope of Genesys Capital's investments?
The firm primarily focuses on North America, with a particular emphasis on opportunities within Canada. They aim to support local startups that are developing innovative healthcare solutions.
What is Genesys Capital's post-investment involvement like?
Genesys Capital actively engages with its portfolio companies, providing operational support, strategic guidance, and access to their extensive network within the life sciences sector. They often take board seats to ensure alignment and support for growth.
What is the typical check size for investments?
While specific check sizes can vary, Genesys Capital is known for providing substantial funding to early-stage companies, aligning with their strategy to support innovative healthcare solutions.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.